Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Maxcyte (MXCT) Inventory Average (2021 - 2025)

Maxcyte (MXCT) has disclosed Inventory Average for 4 consecutive years, with $8.6 million as the latest value for Q1 2025.

  • On a quarterly basis, Inventory Average fell 28.94% to $8.6 million in Q1 2025 year-over-year; TTM through Mar 2025 was $8.6 million, a 28.94% decrease, with the full-year FY2024 number at $10.6 million, up 1.6% from a year prior.
  • Inventory Average was $8.6 million for Q1 2025 at Maxcyte, down from $11.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $12.1 million in Q1 2024 to a low of $4.2 million in Q3 2021.
  • A 4-year average of $7.8 million and a median of $7.8 million in 2022 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: soared 87.95% in 2022, then decreased 28.94% in 2025.
  • Maxcyte's Inventory Average stood at $4.7 million in 2021, then surged by 76.33% to $8.2 million in 2022, then soared by 40.18% to $11.6 million in 2024, then fell by 25.65% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Inventory Average are $8.6 million (Q1 2025), $11.6 million (Q2 2024), and $12.1 million (Q1 2024).